SonoMotion receives FDA Breakthrough Device Designation for Break Wave™ procedure.
Sonomotion raises USD$12.4 Million in Series C funding to advance development of Break Wave™. Round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.
Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).
First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video).
Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release).
SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.